Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-015498
Filing Date
2023-05-23
Accepted
2023-05-22 17:39:28
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arch20230331_10q.htm   iXBRL 10-Q 1031531
2 EXHIBIT 10.1 ex_523712.htm EX-10.1 62466
3 EXHIBIT 10.2 ex_521144.htm EX-10.2 139172
4 EXHIBIT 10.3 ex_521145.htm EX-10.3 91080
5 EXHIBIT 10.4 ex_523713.htm EX-10.4 120553
6 EXHIBIT 10.5 ex_523714.htm EX-10.5 19987
7 EXHIBIT 10.6 ex_523715.htm EX-10.6 20907
8 EXHIBIT 31.1 ex_499766.htm EX-31.1 8840
9 EXHIBIT 31.2 ex_499767.htm EX-31.2 8917
10 EXHIBIT 32.1 ex_499768.htm EX-32.1 7020
  Complete submission text file 0001437749-23-015498.txt   6341268

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA arch-20230331.xsd EX-101.SCH 66277
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arch-20230331_cal.xml EX-101.CAL 27143
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230331_def.xml EX-101.DEF 466306
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230331_lab.xml EX-101.LAB 339055
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230331_pre.xml EX-101.PRE 486167
64 EXTRACTED XBRL INSTANCE DOCUMENT arch20230331_10q_htm.xml XML 729458
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54986 | Film No.: 23945830
SIC: 3841 Surgical & Medical Instruments & Apparatus